Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.
Posted on June 02, 2008 in Prescriptions
AIDS November 2007 \"Circumstances: These observations challenge the current regard of HIV-1 turnover as well compartmentalization. They furthermore aim the warrant of this new integrase inhibitor raltegravir.\"
Tags: raltegravir, hiv, inhibitor, integrase, regard